Document Detail

Autoimmune response and target autoantigens in Sjogren's syndrome.
MedLine Citation:
PMID:  20629708     Owner:  NLM     Status:  In-Process    
BACKGROUND: Primary Sjogren's syndrome (pSS) is characterized by the presence of autoantibodies targeting mainly the Ro/La ribonucleoprotein complex. It is now appreciated that the production of autoantibodies is an antigen-driven immune response.
DESIGN: In this review, candidate mechanisms for autoantigen presentation and perpetuation of the autoimmune response within the autoimmune tissue lesion of pSS are discussed.
RESULTS: Several studies have shown that the epithelial cell in labial salivary glands of patients with Sjogren's syndrome is activated, bearing characteristics of an antigen-presenting cell, as suggested by inappropriate expression of class II HLA and co-stimulatory molecules. Other studies have confirmed that in salivary glands, there is an increased autoantigen presentation via apoptotic blebs and bodies, exosomes and heat shock protein-mediated cross-priming. There is also an increased expression of interferon (IFN)-induced genes, such as the autoantigen Ro52, which provide negative feedback regulation in inflammation. Ro60 and La autoantigens also appear to play a major role in the local autoimmune response in Sjogren's syndrome. In this regard, La and Ro60 the messenger RNA (mRNA) expression is upregulated in the affected salivary glands with different isoforms of La autoantigen mRNA to be expressed in patients with pSS. At the protein level, La/SSB in pSS salivary glands is found to be post-translationally modified.
CONCLUSIONS:  Autoantigen alterations in a microenvironment of local inflammation with increased in situ apoptosis, Toll-like receptor (TLR) signalling and antigen presentation may drive the autoimmune response and local autoantibody production in pSS.
John G Routsias; Athanasios G Tzioufas
Related Documents :
16893498 - Immunoregulatory role of b7-h1 in chronicity of inflammatory responses.
20392288 - Overview of the biology of type i interferons.
15661028 - Foxp3 acts as a rheostat of the immune response.
18613848 - Human regulatory t cells: role in autoimmune disease and therapeutic opportunities.
19531658 - Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 ac...
25055978 - Thioredoxin/thioredoxin reductase system involvement in cerebellar granule cell apoptosis.
Publication Detail:
Type:  Journal Article; Review     Date:  2010-08-19
Journal Detail:
Title:  European journal of clinical investigation     Volume:  40     ISSN:  1365-2362     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  1026-36     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation.
Department of Pathophysiology, School of Medicine, University of Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study.
Next Document:  C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy.